The Journey of SGLT2i at TJUH
In this Shared Learning session, speakers from Cardiology, Endocrinology and Pharmacy at Jefferson Health presented their quality improvement (QI) project focused on the uptake and usage of SGLT2i medications in patients with diabetes and cardiovascular disease. The speakers presented interim updates and results of the QI interventions implemented to date along with the challenges, barriers to usage, successes and next steps for the QI project.
Date: Wednesday, March 3, 2021
Christine Clancy, MSN, CRNP, CDE Jefferson Health Division of Endocrinology, Diabetes and Metabolic Diseases
Mathew Francis, MD PGY 3 Department of Medicine Thomas Jefferson University
Yair Lev, MD Clinical Assistant Professor Cardiology Thomas Jefferson University
Eric Shiffrin, MD Assistant Clinical Professor Division of Endocrinology, Diabetes and Metabolic Diseases Thomas Jefferson University Hospital
